Keywords: فارماکوژنومیک; Pharmacogenomics; Pharmacogenetics; Pharmacokinetic; Pharmacodynamics; P-glycoprotein; Adenosine-triphosphate binding cassette (ABC);
مقالات ISI فارماکوژنومیک (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: فارماکوژنومیک; Personalized medicine; Computational algorithm; Predictive modeling; GWAS; SNPs; Pharmacogenomics;
Keywords: فارماکوژنومیک; Interprofessional education (IPE); Team-based learning (TBL); Telehealth; Medical education; Pharmacy education; Medical students; Pharmacy students; Pharmacogenomics; Pharmacogenomics education;
Keywords: فارماکوژنومیک; Genetic polymorphism; Pharmacogenomics; Non-clinical study; Phase I clinical trial; Precision pharmacotherapy;
Keywords: فارماکوژنومیک; Antipsychotic; Lurasidone; Schizophrenia; Pharmacogenomics; Synaptic adhesion; Polygenic risk;
Keywords: فارماکوژنومیک; Single-nucleotide polymorphism; Loop-mediated isothermal amplification; Point-of-care optical testing; Smartphone; Pharmacogenomics;
Keywords: فارماکوژنومیک; Personalized medicine; Non-small cell lung cancer; Pharmacogenomics; Tyrosine kinase; Anaplastic lymphoma kinase; Inhibitor; Monoclonal antibody;
Keywords: فارماکوژنومیک; Pharmacogenomics; gene expression; inhaled corticosteroids; apoptosis; system biology; CAMP; Childhood Asthma Management Program; DC; Differentially connected; DE; Differentially expressed; FEV1%; FEV1 percent of predicted; ICS; Inhaled corticosteroid; LC
Keywords: فارماکوژنومیک; Genetic; Depression; CYP450; Pharmacodynamics; Pharmacokinetics; Antidepressant; Pharmacogenetics; Pharmacogenomics; Cost-effectiveness; Genesight; CNSDose;
Keywords: فارماکوژنومیک; ADHD; Attention deficit hyperactivity disorder; APOE; Apolipoprotein E; cART; Combinatorial antiretroviral therapy; CEPH-HGDP; Centre d'Ãtude du polymorphisme humain-Human genome diversity panel; dbGaP; Database of genotypes and phenotypes; EGA; Europe
Keywords: فارماکوژنومیک; Transmission; Pharmacogenomics; Incipient tuberculosis; HIV; Diabetes; Biomarkers; DAIDS; Division of AIDS; NIAID; National Institute of Allergy and Infectious Diseases; NIH; National Institutes of Health; TB; tuberculosis; RePORT; Regional Prospective Ob
Keywords: فارماکوژنومیک; clinical decision support; electronic health records; pharmacogenomics; precision medicine;
Keywords: فارماکوژنومیک; Personalized medicine; Autoimmune disease; Immunology diagnosis; Pharmacogenomics;
Keywords: فارماکوژنومیک; Clinical practice; Genetic testing; Pharmacogenomics; Precision medicine; Standardization; Test selection;
Keywords: فارماکوژنومیک; Methotrexate; Anti-TNF; Anti-TNF response; Genetic; Genomic; Rheumatoid arthritis; Pharmacogenomics;
Keywords: فارماکوژنومیک; depression; mental health; pharmacogenomics; primary health care; psychiatry;
Keywords: فارماکوژنومیک; VPA; valproic acid; FABP2; fatty acid binding protein 2; UGT1A6; uridine diphosphate glucuronosyltransferase family 1 member A6; UGT2B7; uridine diphosphate glucuronosyltransferase family 2 member B7; CYP2C9; cytochrome P450 family 2 subfamily C member 9;
Keywords: فارماکوژنومیک; ADME; clinical pharmacokinetics; drug interactions; membrane transporter; organic cation transporters; pharmacogenomics; pharmacokinetics/pharmacodynamics;
Keywords: فارماکوژنومیک; Polypharmacy; Medication risk mitigation; Medication therapy management; Pharmacy practice; Personalized medicine; Pharmacogenomics;
Keywords: فارماکوژنومیک; ISO 15189; Molecular diagnostics; Infectious diseases; Oncology; Inherited diseases; Pharmacogenomics; Molecular requisition; Informed consent; Specimen integrity; Molecular pathology; Standardization; Good laboratory practice; Pre-analytic; Pre-examinati
Keywords: فارماکوژنومیک; Acute lymphoblastic leukemia; 6-Mercaptopurine; Methotrexate; Pharmacogenomics; Maintenance therapy;
Keywords: فارماکوژنومیک; Human leukocyte antigen; T-cell receptor; Adverse drug reaction; Pharmacogenomics; Human herpes virus; Drug reaction with eosinophilia and systemic symptoms; Steven Johnson syndrome; Toxic epidermal necrolysis;
Keywords: فارماکوژنومیک; Drug efficacy; drug safety; individual variability; personalized medicine; pharmacodynamics; pharmacogenetics; pharmacogenomics; pharmacokinetics; precision medicine; stratified medicine
Keywords: فارماکوژنومیک; Advanced manufacturing; Pharmacogenomics; Patient involvement; Digital health
Keywords: فارماکوژنومیک; Genetic polymorphism; Pharmacogenomics; VIP variants; Li ethnicity;
Keywords: فارماکوژنومیک; genetic polymorphisms; genome-wide association studies; intravenous immunoglobulin resistance; Kawasaki disease; pharmacogenomics
Keywords: فارماکوژنومیک; Genome-wide association study; Human leukocyte antigen; Pharmacogenomics; Schizophrenia; Side effect; Single nucleotide polymorphism;
Keywords: فارماکوژنومیک; Clinical trials; Population; Cardiometabolic risk; Registry-based randomised trials; Pharmacogenomics; Lipoprotein(a); Triglyceride-rich lipoprotein cholesterol;
Keywords: فارماکوژنومیک; Bladder cancer; Pharmacogenomics; Precision medicine; Treatment response prediction;
Keywords: فارماکوژنومیک; BD; Bipolar Disorder; STEP-BD; Systematic Treatment Enhancement Program for Bipolar disorder; DFNB31; Deafness, Autosomal Recessive 31; SORCS2; Sortilin-Related VPS10 Domain Containing Receptor 2; NRXN1; Neurexin 1; CNTNAP2; Contactin Associated Protein-L
Keywords: فارماکوژنومیک; Cardiovascular disease; Hypertension; Embryonic programming; Epigenetics; Pharmacogenomics; Glucocorticoids
Keywords: فارماکوژنومیک; Genomics; Pharmacogenomics; Clinical care;
Keywords: فارماکوژنومیک; Allergy; asthma; atopic dermatitis; exposome; gene-environment interactions; metabolome; microbiome; personalized medicine; pharmacogenomics; stratified medicine; DBPCFC; Double-blind, placebo-controlled food challenge; LEAP; Learning Early About Peanut;
Keywords: فارماکوژنومیک; Chemotherapy-induced cardiotoxicity; pharmacogenomics; human induced pluripotent stem cells; cardiomyopathy;
Keywords: فارماکوژنومیک; Pharmacogenomics; Pharmacogenetic; Acute kidney disease; CKD;
Keywords: فارماکوژنومیک; ABC, ATP-binding cassette; IC50, 50% inhibition concentration; MDR, multidrug resistance; NCI, National Cancer Institute; (P-gp), P-glycoproteinABC transporters; Chemotherapy; Multidrug resistance; Natural products; Pharmacogenomics; Phytotherapy
Keywords: فارماکوژنومیک; Pharmacogenetics; Pharmacogenomics; Cancer; Resistance; Somatic mutations
Keywords: فارماکوژنومیک; Antihypertensive; Pharmacogenomics; Implementation; Cytochrome P450;
Keywords: فارماکوژنومیک; anticoagulant therapy; mitochondrial DNA; pharmacogenomics; warfarin
Keywords: فارماکوژنومیک; Genomic biomarkers; Protein profiling; Molecular carcinogenesis; Pharmacogenomics
Keywords: فارماکوژنومیک; Genomic profiling; Gene therapy; Mutations; Pancreatic cancer; Pharmacogenomics; SLC39A4 (ZIP4);
Keywords: فارماکوژنومیک; Schizophrenia; Neurocognition; Folate; Pharmacogenomics; Endothelial function; Cardiovascular disease;
Keywords: فارماکوژنومیک; Psychotropics; Bio-psycho-social model; Psychiatry; Pharmacogenomics; Personalized medicine
Keywords: فارماکوژنومیک; USA; Pharmacogenomics; Personalised medicine; FDA; Pharmaceutical regulation; Neoliberalism; Technocracy; Bioeconomy;
Keywords: فارماکوژنومیک; Absorption; affinity; bioavailability; biomarkers; cancer; clinical pharmacology; disposition; drug interactions; efficacy pharmacodynamics; pharmacogenomics; pharmacokinetics; potency; receptors; targeted therapies; transporters
Keywords: فارماکوژنومیک; Major depressive disorder; Bipolar disorder; Personalized medicine; Precision medicine; Pharmacogenomics; Epigenetics;
Keywords: فارماکوژنومیک; Toremifene; Tamoxifen; Metabolite kinetics; Bioactivation; CYP2D6; CYP3A4; CYP2C9; Pharmacogenomics; PolymorphismsTOR, toremifene; TAM, tamoxifen; SERM, selective estrogen receptor modulator; SSRI, selective serotonin reuptake inhibitor; 4OH, 4-hydroxy; N
Keywords: فارماکوژنومیک; Jaw osteonecrosis; Bisphosphonates; Pharmacogenetics; Pharmacogenomics; Genes; Single-nucleotide polymorphisms;
Keywords: فارماکوژنومیک; placebo; RCT; COMT; no treatment control; pharmacogenomics
Keywords: فارماکوژنومیک; Cancer; Cell death; Iron; Microarray; Pharmacogenomics; DAB; diaminobenzidine; IC50; 50% inhibition concentration; NCI; National Cancer Institute USA; ROS; reactive oxygen species; TFRC; transferrin receptor;